FTFinancial Times·5hHealth
score-0.40
US Advisory Panel Weighs Effectiveness Concerns for Cancer-Screen Blood Test Amid UK Study Failure
Original
Cancer-screen blood test wins tepid support from US drug advisory panel
“The use of 'tepid support' and highlighted concerns reflects a cautious, skeptical tone rather than outright negativity or failure.”